TechCruch selects CellChorus for Startup Battlefield 200 at TechCrunch Disrupt
Fewer than 50 health and bio companies selected to present at TechCrunch event in San Francisco from September 19th to 21st
HOUSTON, Texas — August 24, 2023 — CellChorus Inc. today announced that TechCrunch has selected CellChorus to present at TechCrunch Disrupt 2023 in the Startup Battlefield 200 program. CellChorus is one of 200 startups—and fewer than 50 health/bio companies—selected from a review of thousands of applicants. This year’s Startup Battlefield participants span artificial intelligence (AI), healthtech, tech-bio, software as a service (SaaS), fintech, security, sustainability, space exploration, and more.
CellChorus® merges visual AI, advanced microscopy, and microscale manufacturing to visually evaluate thousands of cell-cell interactions in parallel. The company applies Time lapse Imaging Microscopy in Nanowell Grids™ (TIMING™) with neural network-based detection to identify which cells perform best—and why. CellChorus customers include leading researchers, developers and manufacturers of cell therapies and antibody therapeutics.
“We are pleased to be recognized by the TechCrunch team for an event the features some of the most exciting high-growth companies across AI, tech-bio, hardware, and other sectors,” said Daniel Meyer, CEO of CellChorus.
TechCrunch Disrupt 2023 will be held from Tuesday, September 19th to Thursday, September 21st at the Moscone Center in San Francisco. The event is known for debuting the hottest startups, introducing game-changing technologies, and discussing what is top-of-mind for the tech industry’s key innovators. Past companies that have presented at Disrupt include Cellino Bio, Cloudflare, Dropbox, Fitbit and Mint.
For more information on TechCrunch Disrupt 2023 and Startup Battlefield 200 visit the conference website here. Disrupt passes can be purchased here. The list of life sciences, medical device, healthcare services, and other health/bio companies is available here.
About CellChorus
CellChorus® is the leader in applying artificial intelligence to quantify the function and performance of cells over time to improve the development and delivery of novel therapies that improve patient care. The company applies Time-lapse Imaging Microscopy In Nanowell Grids™ (TIMING™) with neural network-based detection to identify how cells move, activate, kill, and survive at single-cell resolution. The patent-protected platform can link TIMING data and insights with information from other analysis modalities such as single-cell RNA sequencing to provide a comprehensive understanding of cellular function, state and phenotype. Please visit cellchorus.com for more information.
About Startup Battlefield
TechCrunch’s Startup Battlefield 200 is the world’s preeminent startup competition. Startup Battlefield 200 will showcase the top 200 startups from around the globe, across multiple industries. All 200 companies will go through training, have access to masterclasses, private receptions, communities and investor meet and greets. Companies that launched on our stage include Vurb, Trello, Mint, Dropbox, Yammer, Tripit, Redbeacon, Qwiki, Getaround, and Soluto.
About TechCrunch Disrupt
TechCrunch Disrupt is the world’s leading authority in debuting revolutionary startups, introducing game-changing technologies, and discussing what’s top of mind for the tech industry’s key innovators. This year, Disrupt gathers the best and brightest entrepreneurs, investors, hackers, and tech fans virtually and in-person for interviews, demos, Startup Battlefield 200, Networking, and more.
Company Contact:
Daniel Meyer
CellChorus Inc.
TIMING@cellchorus.com
Source: https://cellchorus.com/news/techcruch-selects-cellchorus-for-startup-battlefield-200
